Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Chordate Medical enters agreement in Switzerland

Chordate Medical adds Switzerland as a new focus market for the Ozilia migraine treatment entering into a new partnership agreement with Neurolite, a well-established distributor in neurology in Switzerland.– Neurolite has a complete grasp of the entire neurology market, with well-established relationships with a large portion of all relevant customers, says Chordate’s CEO Anders Weilandt.Read the full article at biostock.se : https://www.biostock.se/en/2024/06/chordate-medical-enters-agreement-in-switzerland/ This is a press release from BioStock -

BioStock: Elicera teams up with China Medical University for cancer study

Elicera Therapeutics has announced a new research collaboration with the Fourth Affiliated Hospital of China Medical University to assess the efficacy of oncolytic virus ELC-201 in preclinical proof-of-concept studies. This collaboration will explore the potential of ELC-201 across various solid tumour indications. BioStock turned to Elicera’s CEO Jamal El-Mosleh to learn more.Read the article at biostock.se: Elicera teams up with China Medical University for cancer study - BioStock 

Repurchase of Truecaller B shares in week 24, 2024

During 10 June 2024 and 14 June 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 450,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up until the 2025 AGM which will be held in May 2025, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2024 the Board was authorized to buy back B-shares up until the Annual

Comment to Press Release regarding unilateral liquidation application issued by Ayima

On Friday evening 14 June, WPTG’s subsidiary Ayima sent out a Press Release regarding the company’s voluntary liquidation application. The Press Release was not sanctioned by the board of its parent company, WTPG, and contains several inaccuracies.Subsequent to WPTG’s acquisition of Ayima  in March 2024, following a review of operations, WPTG injected a loan of 3 MSEK during April 2024 to enable Ayima to meet its cash commitments. This cash requirement was known at the time of the acquisition. WPTG’s investigations in June 2024 discovered that the cash requirements in Ayima’s business had

Statement by the Board of Directors in relation to the withdrawal of the public offer from Greenoaks and Long Path

On 5 June 2024, Greenoaks Capital Partners and Long Path Partners (the “Bid Consortium”) announced, through Forseti III AB (“BidCo”), that their public offer (the “Offer”) to the shareholders of Karnov Group AB (publ) (“Karnov Group”) had only been accepted by shareholders representing 25.7 per cent of all shares in Karnov Group and that the acceptance period was extended to 14 June 2024. Today on 17 June 2024, BidCo announced that the Offer had only been accepted by shareholders representing 26.2 per cent of all shares in Karnov Group by the end of the extended acceptance period, and that

Greenoaks and Long Path announce final outcome of the cash offer to the shareholders of Karnov Group AB (publ) and withdraw the offer

This announcement is not an offer, whether directly or indirectly, in Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the

Epiroc completes acquisition of Canadian ground support business

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, has completed the acquisition of the business of Yieldpoint Inc., a Canadian company that provides advanced ground support solutions that strengthen safety for mining and civil engineering applications.Yieldpoint is based in Kingston, Ontario, Canada, and has about 10 employees. The company designs, manufactures and sells advanced digital geotechnical instruments, and has customers worldwide. The products, which include ground movement sensors and telemetry solutions, are

BEWI initiates strategic review of the automotive business

BEWI ASA, a leading provider of packaging, components, and insulation solutions, today announces that the group is initiating a strategic review process for its automotive business. BEWI’s automotive business is a leading specialist in the manufacturing of advanced insulation and soundproofing solutions for the automotive industry. The activities are currently reported under the group’s Packaging & Components segment and includes BEWI’s ownership interest in the listed Polish automotive company IZOBLOK Spólka Akcyjna ("IZOBLOK"), as well as the group’s automotive activities in Sweden. In

DNB Bank ASA will buy back up to 1.0 percent of the company’s own shares

DNB Bank ASA has decided to initiate a share buy-back programme comprising up to 1.0 percent of the company’s own shares, which represents a total of 14,925,301 shares. The buy-back programme was adopted based on an authorisation given by the Annual General Meeting held on 29 April 2024. The Financial Supervisory Authority of Norway has approved the buy-back programme, on the condition that the total buy-backs do not reduce the company’s own funds by more than NOK 3,358 million. The purpose of the buy-back programme is to optimise the company’s capital structure, by reducing the common

Boliden Harjavalta aims to become the frontrunner in metal industry in collaboration with Etteplan

ETTEPLAN OYJ, Press release, June 17, 2024 at 9.15 a.m. (EEST) Boliden Harjavalta aims to become the frontrunner in metal industry in collaboration with Etteplan  Boliden Harjavalta and Etteplan have signed a cooperation agreement to provide engineering services for Boliden Harjavalta's facilities in Pori and Harjavalta. Etteplan's expertise in engineering solutions and production process know-how complement Boliden Harjavalta's needs, especially in operational optimization and digital engineering process management.   At the same time, Etteplan and Metso have agreed on a business

Wyld Networks working with Harper Adams University in the UK monitoring soil data via Wyld Connect satellite IoT

Harper Adams University is the foremost university in the UK for agriculture, animal and rural management, and environmental management. It has set the gold standard for UK agricultural research, tackling some of the most pressing issues facing the world – food security, land management, sustainability and climate challenges. Wyld are working with Harper Adams to monitor soil for crops with an initial project to deliver soil moisture data for brassicas within the 550 hectares of the Harper Adams research fields in Shropshire UK. Managing soil health and water usage are key to maximising

Imfinzi approved in the US for endometrial cancer

17 June 2024   Imfinzi plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy   AstraZeneca’s Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (dMMR).1   The approval by the Food and

CapMan Real Estate announces strategic promotions and new role to bolster Nordic asset management

CapMan Real Estate press release17.6.2024 at 09:00 AM EEST CapMan Real Estate announces strategic promotions and new role to bolster Nordic asset management CapMan Real Estate makes key organisational enhancements including the introduction of a new leadership role to streamline Nordic asset management operations and support continued expansion. Over recent five years, CapMan Real Estate has experienced substantial growth, with gross asset value under management surging by over €1 billion, reaching approximately €4.4 billion. The pan-Nordic team has also seen significant growth,

Invitation to presentation of Alligo’s Interim Report for the second quarter 2024

Alligo will publish its Interim Report for the second quarter on Wednesday July 17, 2024 at 8:00 a.m. CEST. In conjunction with this, Alligo is pleased to issue this invitation to a webcast conference call in which CEO & President Clein Johansson Ullenvik and CFO Irene Wisenborn Bellander will present the report and answer any subsequent questions.The conference call and presentation are available on the web or by telephone in accordance with the details below. Questions can be asked via the webcast  (written) or by logging in to the conference

The last day for trading in Moberg Pharma's warrants of series 2023:1 (TO 2) is today, June 17[th], 2024

Today, June 17[th], 2024, is the last day for trading in Moberg Pharma AB's (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2023:1 (“TO 2”). The exercise period runs until June 19[th], 2024.In 2023, Moberg Pharma carried out a rights issue of units which was oversubscribed to approximately 130%. Each unit consisted of one (1) ordinary share and one (1) warrant in Moberg Pharma. One (1) warrant of TO 2 entitles the holder to subscribe for one (1) new ordinary share in Moberg Pharma. The subscription price is SEK 18.00 per share. TO 2 in briefEach TO 2 entitles the holder

Volvo Defense at Eurosatory 2024: a complete solution designed for the toughest conditions

At this year’s Eurosatory – the world’s largest international defence and security exhibition – Volvo Defense will be showcasing how equipment from Volvo Trucks, Volvo Penta, and Volvo Construction Equipment can offer customers the highest level of flexibility and security of supply.The Volvo Defense offer is built on the strength of the Volvo Group, having a unique product range for the military defence and civilian protection segment. “I’m excited to meet and interact with customers and industry stakeholders at Eurosatory – Volvo Defense has a stronger offer than ever before”, says

Transaction in Own Shares

    17 June 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |14/06/2024|+--------------------------------------------------------------

Olvi plc: Transfer of Treasury Shares Under a Matching Share Plan

Olvi plc           Stock Exchange Release 17 June 2024 at 9.00 am Olvi plc: Transfer of Treasury Shares Under a Matching Share Plan The Board of Directors of Olvi plc has resolved on directed issuance of shares without consideration to transfer a total of 400 Olvi plc Series A shares held as treasury shares to the company's key employees under a Matching Share Plan 2022–2023. In the plan, the target group was given an opportunity to receive matching shares for their personal investment in Olvi plc series A shares. The rewards depend on the validity of the employment relationship at

Africa Oil Announces Results of Share Buyback Program

VANCOUVER, BC, June 17, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 1,244,300 Africa Oil common shares during the period of June 10, 2024 to June 14, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/1052 (

Norconsult ASA: Employee Share Programs 2024

Sandvika, 17 June 2024(OSE: NORCO): In connection with Norconsult’s Employee Share Programs 2024, 3 839 employees purchased a total of 2 885 363 shares. The share programs were substantially oversubscribed, hence the allocation of shares was reduced in order to meet the previously communicated cost frame for the program. The Share Programs include a program for discounted shares and matching shares, as well as programs for executive management and other key employees. For discounted shares, the purchase price is equal to the volume-weighted average share price for the Company's shares on

SRV and Metsä Group reach agreement on the development phase of a fibre products factory

SRV GROUP PLC     INVESTOR NEWS    17 JUNE 2024  09:00 EEST SRV and Metsä Group reach agreement on the development phase of a fibre products factory SRV and Metsä Group have signed an agreement to start the development phase of a new fibre products factory of approximately 20,000 square metres to be designed on the Rauma factory area. The new packaging materials production facility using wood fibres would use a completely new manufacturing method. The goal of preliminary planning during the development phase is to find out the project's investment suitability by the turn of the year.

Sobi to present new haemophilia data at ISTH 2024

Sobi® will present new scientific data related to haemophilia at ISTH 2024, the 32nd Congress of the International Society on Thrombosis and Haemostasis. This event, taking place from 22nd to 26th June, will be held both online and in Bangkok. Seven abstracts have been accepted for presentation (three posters and four oral). New long-term safety and efficacy data on efanesoctocog alfa and long-term efficacy data on Elocta will be presented further demonstrating Sobi's commitment to advancing standards of care in haemophilia A treatment.   “We are pleased to present new data at this

Kemira Oyj: Announcement of manager’s transaction; Esa-Matti Puputti, EVP, Operational Excellence & Sustainability has sold 15,000 Kemira shares

Kemira Oyj, Managers' transactions, June 17, 2024 at 9.00 am (EEST)Kemira Oyj: Announcement of manager’s transaction; Esa-Matti Puputti, EVP, Operational Excellence & Sustainability has sold 15,000 Kemira sharesKemira has received a notification from Esa-Matti Puputti, EVP, Operational Excellence & Sustainability, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below. Person subject to the notification requirementName: Esa-Matti PuputtiPosition: Other senior managerIssuer:

There are no items matching the current filter
There are no more items matching the current filter
Back to top